Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients

High-dose chemotherapy with peripheral blood stem cell (PBSC) transplantation in advanced germ cell tumour (GCT) patients is widely applied. The aims of this study were: (1) To examine the presence of alphafetoprotein (AFP) bearing tumour cells in PBSC harvests from advanced GCT patients obtained after multiple cycles of induction chemotherapy. (2) To determine whether induction chemotherapy contributed to in vivo purging of the tumour. We evaluated cryopreserved PBSC samples from 5 patients with advanced stage II/III AFP producing GCT. PBSC were separated after the first, second and third cycles of induction chemotherapy. Those samples were analysed using the nested reverse transcription polymerase chain reaction (RT-PCR) method to detect AFP mRNA. Although, in all patients, AFP mRNA was detected in PBSC samples after the first or second cycle of induction chemotherapy, but was not detected in 3 of 4 samples after the third cycle of chemotherapy. Although it is not clear whether tumour cells contaminating PBSC fraction contribute to disease relapse, PBSC harvested after at least 3 cycles of induction chemotherapy might be recommended to avoid such a possibility. © 2001 Cancer Research Campaign http://www.bjcancer.com

[1]  J. Rosai,et al.  Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Bosi,et al.  Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA , 1998, British journal of haematology.

[3]  H. Lazarus,et al.  Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Johnson,et al.  Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. , 1998, British Journal of Cancer.

[5]  V. Bilim,et al.  Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC). , 1998, Anticancer research.

[6]  B. Groner,et al.  Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxins. , 1998, Blood.

[7]  K. Cornetta,et al.  Detection of germ cell tumor cells in apheresis products using polymerase chain reaction. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  D. Berry,et al.  The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  G. Schlimok,et al.  Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients , 1997, Bone Marrow Transplantation.

[10]  K. Cornetta,et al.  Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer , 1997, Cancer.

[11]  B. Dörken,et al.  Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. , 1997, Blood.

[12]  D. Huhn,et al.  Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy , 1997, Cancer.

[13]  L. Kanz,et al.  Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells. , 1996, Blood.

[14]  N. Davidson,et al.  Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Perkins,et al.  Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Lotz,et al.  Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. , 1995, Bone marrow transplantation.

[17]  N. Nishida,et al.  Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood , 1995, Cancer.

[18]  J. Perkins,et al.  Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Craig,et al.  Molecular detection of tumor contamination in peripheral blood stem cell harvests. , 1994, Experimental hematology.

[20]  N. Davidson,et al.  Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Rill,et al.  Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. , 1994, Blood.

[22]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[23]  L. Mattano,et al.  Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. , 1992, Cancer research.

[24]  D. Trump,et al.  High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Gribben,et al.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.

[26]  B. Bostrom,et al.  Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. , 1990, Blood.

[27]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[28]  T. Tamaoki,et al.  Primary structures of human alpha-fetoprotein and its mRNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.